Related Experiment Video
Updated: Oct 22, 2025
08:44
Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
Published on: September 7, 2022
2.6K
EBV-positive mucocutaneous ulceration.
Annals of the Royal College of Surgeons of England
|August 26, 2021
Summary
Epstein-Barr virus (EBV)-related oral ulceration is a rare condition that can mimic lymphoma. This case highlights successful treatment using conservative measures alone.
Area of Science:
- Oral medicine
- Infectious diseases
- Pathology
Background:
- Oral ulceration is a common condition, frequently requiring specialist care.
- Epstein-Barr virus (EBV)-related mucocutaneous ulceration is a recently described, rare cause of oral lesions.
Observation:
- The presented case involved a rare EBV-induced oral ulceration.
- Histological examination revealed features similar to lymphomas.
Findings:
- EBV-related oral ulceration requires distinct management and has a different prognosis compared to lymphomas.
- Conservative treatment measures were effective in resolving the oral ulceration in this case.
Implications:
- Accurate diagnosis of EBV-induced oral ulceration is crucial to avoid misclassification with lymphomas.
- Conservative management can be a successful therapeutic approach for EBV-related oral ulceration.
- Further research into EBV-related oral lesions is warranted to understand their pathogenesis and optimize treatment strategies.
Related Concept Videos
01:30Skin Cancer
4.9K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.9K
01:24Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
834
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
834
01:24Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
692
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
692
01:25Mucosal Barrier of the Stomach
983
The gastric glands contain parietal cells that secrete hydrochloric acid (HCl) for digestion. The cells secrete HCl because it is highly corrosive and essential for breaking down food. To achieve this, they secrete hydrogen and chloride ions into the lumen of the gastric glands, which combine to form HCl.
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
983
01:26Peptic Ulcer Disease IV: Management
177
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
177
01:28Peptic Ulcer Disease II: Pathophysiology
1.1K
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
1.1K